BCIQ Profiles

Company Profile Report
0330 QT Fin
BioCentury & Getty Images


March 30 Quick Takes: BioNTech anticipates €9.8B year; plus Immune-Onc, Amgen-Rodeo, Stuart, Bond

Mar 30, 2021 | 7:22 PM GMT

BioNTech making plans around €9.8B year for vaccine sales
With estimated 2021 revenue of €9.8 billion ($11.5 billion) from sales

Read the full 428 word article

How to gain access

Continue reading with a
two-week free trial.